Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $365.1M
Liabilities Breakdown FY2016
Total Liabilities: $50.2M
Asset Breakdown
Total Assets: $365.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $83.3M | 22.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.3M | 1.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $275.5M | 75.5% |
Liabilities Breakdown
Total Liabilities: $50.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.1M | 10.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $45.1M | 89.9% |